Correlation Between Orgenesis and Achilles Therapeutics

Can any of the company-specific risk be diversified away by investing in both Orgenesis and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orgenesis and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Orgenesis and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Orgenesis and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orgenesis with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orgenesis and Achilles Therapeutics.

Diversification Opportunities for Orgenesis and Achilles Therapeutics

0.63

Correlation Coefficient

Orgenesis  Achilles Therapeutics

Poor diversification

The 3 months correlation between Orgenesis and Achilles is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Orgenesis and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Orgenesis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orgenesis are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Orgenesis i.e., Orgenesis and Achilles Therapeutics go up and down completely randomly.

Pair Corralation between Orgenesis and Achilles Therapeutics

Given the investment horizon of 90 days Orgenesis is expected to under-perform the Achilles Therapeutics. In addition to that, Orgenesis is 2.87 times more volatile than Achilles Therapeutics PLC. It trades about -0.13 of its total potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about 0.04 per unit of volatility. If you would invest  86.00  in Achilles Therapeutics PLC on September 22, 2024 and sell it today you would earn a total of  12.00  from holding Achilles Therapeutics PLC or generate 13.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	67.19%
Values	Daily Returns

Orgenesis  vs.  Achilles Therapeutics PLC

Orgenesis

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Orgenesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Achilles Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Achilles Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical indicators, Achilles Therapeutics is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Orgenesis and Achilles Therapeutics

The main advantage of trading using opposite Orgenesis and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orgenesis position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.

The idea behind Orgenesis and Achilles Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.